“Herd” Immunity (Redux)
Biotech companies are working feverishly to develop antibody therapies to provide short-term protection against COVID-19. But what if the novel coronavirus mutates and outwits traditional monoclonal antibodies? Well, that’s where the super cows come in. Hosted by Jim Greenwood.
June 29, 202036m 14s
Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Biotech companies are working feverishly to develop antibody therapies to provide short-term protection against COVID-19. But what if the novel coronavirus mutates and outwits traditional monoclonal antibodies?
Well, that’s where the super cows come in.
Hosted by Jim Greenwood.
Topics
herd immunityantibodybiotechnologybioantibodiescowssciencebiotechvaccinecovid19corona virus